Welcome
NanGenex, member of the DRGT Group, is a Druggability Enabling High Throughput NanoActive™ Technology Platform Company. The company utilizes its integrated platform to provide breakthrough solutions to pharmaceutical and biotech companies in order to develop new generations of NanoActive products with significant performance benefits over conventional approaches.
The technology platform enables NanGenex to generate proprietary NanoActive™ materials by altering their physico-chemical properties to substantially improve their solubility, dissolution rate and bioavailability.
News
Latest Press ReleaseSAN FRANCISCO, CA, January 12, 2012 Druggability Technologies Holdings Limited (DRGT), a privately held biotechnology platform company, announced today that it has completed an initial round of financing totaling $4,000,000. Read more |
|
Latest events 30 April - 1 May 2012, San Diego, USA Drug Delivery and Formulation America 2012 19-22 March, 2012, Istanbul, Turkey 8th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology 1-2 March, 2012, Krems, Austria BioNanoMed 2012
Upcoming events 18-21 June 2012, Boston, USA Bio International Convention 2012 15-17 July 2012, Amsterdam, Netherlands Colloids and Nanomedicine 2012 17 - 19 September 2012, Budapest, Hungary 6th European Pharma Licensing Symposium Budapest 9-11 October 2012, Madrid, Spain CPHI 2012
|